Of the mutations, the R3008H mutation has been previously observed in multiple cancers, including pancreatic cancer, chronic lymphocytic leukemia, mantle cell lymphoma, and diffuse large B cell lymphoma and has been shown to decrease expression of ATM in mantle cell lymphoma, suggesting that it is associated with a loss-of-function [28–32]. This evidence concerns the gene ATM and mantle cell lymphoma.